LTRN
Lantern Pharma Inc. Common Stock
$3.230+-0.000 (-0.000%)
Preço em tempo real
Gráfico de preços
Loading Chart...
Métricas-chave
Métricas de mercado
Abertura
$3.230
Máximo
$3.230
Mínimo
$3.230
Volume
0.11M
Fundamentos da empresa
Estatísticas de negociação
Notícias relacionadas
BusinessWire
Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates
Completion of LP-184 Phase 1a clinical trial enrollment with 62-65 patients across a range of solid tumors expected by end of June 2025. Additional patient data readout from the HARMONIC™ Trial evaluating
Ver mais
BusinessWire
Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC)
The FDA has cleared the investigational new drug (IND) application of LP-184 in triple negative breast cancer (TNBC) treatment – a novel small molecule advanced and developed with Lantern's AI platform,
Ver mais
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.